COMMUNIQUÉS West-GlobeNewswire

Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Cancer and Gene Therapy Treatment
11/04/2019
NEW YORK, April 11, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing [...]
Ultragenyx to Present Corporate Update at Analyst and Investor Day on April 17 in New York
11/04/2019
NOVATO, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Cannabis Retail Giants: 5 Companies Making Big Moves
11/04/2019
VANCOUVER, British Columbia, April 11, 2019 (GLOBE NEWSWIRE) -- The cannabis industry is evolving rapidly, and we've seen some big moves happening lately that are going to have a significant impact on the retail [...]
Minerva Neurosciences Presents Pre-Clinical Data Suggesting a Mechanistic Role of Roluperidone in Addressing Negative Symptoms of Schizophrenia
11/04/2019
Findings show roluperidone increases release and gene expression of BDNF, as well as release of GDNF Data presented at 2019 Congress of the Schizophrenia International Research Society WALTHAM, Mass., April 11, 2019 ( [...]
Progressive Care Inc. Garners Coverage in International Business Times
11/04/2019
MIAMI, April 11, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered media coverage in International Business [...]
Integra LifeSciences Introduces New Codman Specialty Surgical Products at AANS 2019
11/04/2019
New innovations designed to help advance patient care PLAINSBORO, N.J., April 11, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, announced [...]
ContraVir Pharmaceuticals to Present CRV431 Phase 1 Data at the International Liver Congress™
11/04/2019
EDISON, N.J., April 11, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from [...]
aTyr Pharma Announces $5 Million Registered Direct Offering led by The Federated Kaufmann Small Cap Fund
11/04/2019
SAN DIEGO, April 11, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Obalon Engages Cowen to Explore Financial and Strategic Alternatives
11/04/2019
SAN DIEGO, April 11, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Eve & Co Announces $10 Million Special Warrant Bought Deal Financing
11/04/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, April 11, 2019 (GLOBE [...]
Prominent Arkansas Health Plan Partners with Tabula Rasa Healthcare’s PrescribeWellness to Improve Quality & Performance Outcomes for its Members
11/04/2019
Pharmacies leverage Tabula Rasa HealthCare’s patient engagement tools and eCare platform to drive adherence among Arkansas member population MOORESTOWN, N.J. and IRVINE, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Tabula [...]
Translate Bio Appoints Robert Plenge, M.D., Ph.D., to its Board of Directors
11/04/2019
-- Appointment adds deep translational medicine expertise to support the Company’s mission of developing mRNA therapeutics for rare genetic diseases -- LEXINGTON, Mass., April 11, 2019 (GLOBE NEWSWIRE) -- Translate Bio [...]
Otonomy Initiates Phase 1/2 Clinical Trial of OTO-313 in Tinnitus
11/04/2019
Results expected in first half of 2020 SAN DIEGO, April 11, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, [...]
Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
11/04/2019
– Initiation of Phase 2 clinical trial expected in Q2 2019 – – IBAT inhibition has potential to impact key markers of NASH – BOSTON, April 11, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical- [...]
Iterum Therapeutics Presents Data on Risks for Treatment Failure Associated with Uncomplicated Urinary Tract Infection and Activity of its Novel Antibiotic Sulopenem at ECCMID 2019
11/04/2019
The highest risk of treatment failure is seen in patients previously infected with a resistant pathogen. Sulopenem has in vitro activity against isolates of Neisseria gonorrhoeae non-susceptible to quinolones, [...]
Aleafia Health Increases Strategic Investment in Australian LP CannaPacific
11/04/2019
CannaPacific Also Closes its Acquisition of 108,000 sq. ft. Greenhouse for Cannabis Cultivation Australian LP is Federally Licensed to Cultivate and Research Cannabis TORONTO and NEWCASTLE, New South Wales, April 11, [...]
Assembly Biosciences Presents Data Highlighting Next-Generation HBV Core Protein Inhibitors at EASL 2019
11/04/2019
Phase 1a study of ABI-H2158 demonstrated safety, tolerability and achievement of target liver concentrations ABI-H3733 demonstrated enhanced potency in preclinical studies HBV cccDNA shown to have a limited half-life, [...]
Zealand Pharma to attend ABG Sundal Collier Small & Mid Cap Seminar
11/04/2019
Press release – No. 08 / 2019 Zealand Pharma to attend ABG Sundal Collier Small & Mid Cap Seminar Copenhagen, April 11, 2019 – Adam Steensberg, Interim Chief Executive Officer, will attend the ABG Sundal Collier [...]
Trillium Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
11/04/2019
TORONTO, April 11, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL) , a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it [...]

Pages